ATE133863T1 - Therapeutisches mittel gegen glaukom, das 2- phenyl-3-oxo-2h-1,4-benzothiazinderivate enthält - Google Patents

Therapeutisches mittel gegen glaukom, das 2- phenyl-3-oxo-2h-1,4-benzothiazinderivate enthält

Info

Publication number: ATE133863T1
Authority: AT; Austria
Prior art keywords: oxo; phenyl; therapeutic agent; agent against; benzothiazine derivatives
Prior art date: 1990-11-29

Application number

AT91120212T

Other languages

English (en)

Inventor

Shiro Mita

Eiichi Shirasawa

Original Assignee

Santen Pharmaceutical Co Ltd

Daiichi Seiyaku Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-11-29

Filing date

1991-11-26

Publication date

1996-02-15

1991-11-26 Application filed by Santen Pharmaceutical Co Ltd, Daiichi Seiyaku Co filed Critical Santen Pharmaceutical Co Ltd

1996-02-15 Application granted granted Critical

1996-02-15 Publication of ATE133863T1 publication Critical patent/ATE133863T1/de

Links

239000003814 drug Substances 0.000 title abstract 3
229940124597 therapeutic agent Drugs 0.000 title abstract 3
208000010412 Glaucoma Diseases 0.000 title abstract 2
DLALSZUJBMNOHZ-UHFFFAOYSA-N 2-phenyl-4h-1,4-benzothiazin-3-one Chemical class O=C1NC2=CC=CC=C2SC1C1=CC=CC=C1 DLALSZUJBMNOHZ-UHFFFAOYSA-N 0.000 title 1
RKXVEXUAWGRFNP-MUUNZHRXSA-N (2r)-2-[2-[3-[2-(1,3-benzodioxol-5-yloxy)ethyl-methylamino]propoxy]-5-methoxyphenyl]-4-methyl-1,4-benzothiazin-3-one Chemical compound S1C2=CC=CC=C2N(C)C(=O)[C@H]1C1=CC(OC)=CC=C1OCCCN(C)CCOC1=CC=C(OCO2)C2=C1 RKXVEXUAWGRFNP-MUUNZHRXSA-N 0.000 abstract 1
239000004480 active ingredient Substances 0.000 abstract 1
230000004410 intraocular pressure Effects 0.000 abstract 1
239000000546 pharmaceutical excipient Substances 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
238000007910 systemic administration Methods 0.000 abstract 1
238000011200 topical administration Methods 0.000 abstract 1
230000000699 topical effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Ophthalmology & Optometry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Medicinal Preparation (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

AT91120212T 1990-11-29 1991-11-26 Therapeutisches mittel gegen glaukom, das 2- phenyl-3-oxo-2h-1,4-benzothiazinderivate enthält ATE133863T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP33333290		1990-11-29

Publications (1)

Publication Number	Publication Date
ATE133863T1 true ATE133863T1 (de)	1996-02-15

Family

ID=18264932

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT91120212T ATE133863T1 (de)	1990-11-29	1991-11-26	Therapeutisches mittel gegen glaukom, das 2- phenyl-3-oxo-2h-1,4-benzothiazinderivate enthält

Country Status (10)

Country	Link
US (1)	US6281208B1 (de)
EP (1)	EP0492164B1 (de)
JP (1)	JP2975962B2 (de)
KR (1)	KR100190332B1 (de)
AT (1)	ATE133863T1 (de)
CA (1)	CA2056670C (de)
DE (1)	DE69117030T2 (de)
DK (1)	DK0492164T3 (de)
GR (1)	GR3019195T3 (de)
TW (1)	TW207952B (de)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU5511986A (en) *	1985-03-19	1986-10-13	Santen Pharmaceutical Co. Ltd.	2-arylbenzothiazine derivatives
KR890004196B1 (ko) *	1985-07-29	1989-10-27	산텐세이야꾸가부시끼가이샤	신규 벤조티아진 유도체의 제조방법
FR2585574B1 (fr) *	1985-07-31	1988-09-09	Corbiere Jerome	Nouvelles compositions pharmaceutiques anti-glaucomateuses a base de 1,4-dihydropyridines et leur procede d'obtention
FR2593395A1 (fr) *	1986-01-28	1987-07-31	Corbiere Jerome	Nouvelles compositions pharmaceutiques antiglaucomateuses a base de 3-acetoxy-5-(2-dimethylaminoethyl)-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepine-4-one ou d'un de ses sels et leur procede d'obtention

1991
- 1991-11-26 DE DE69117030T patent/DE69117030T2/de not_active Expired - Fee Related
- 1991-11-26 EP EP91120212A patent/EP0492164B1/de not_active Expired - Lifetime
- 1991-11-26 TW TW080109269A patent/TW207952B/zh active
- 1991-11-26 AT AT91120212T patent/ATE133863T1/de not_active IP Right Cessation
- 1991-11-26 DK DK91120212.5T patent/DK0492164T3/da active
- 1991-11-28 JP JP3314546A patent/JP2975962B2/ja not_active Expired - Fee Related
- 1991-11-29 CA CA002056670A patent/CA2056670C/en not_active Expired - Fee Related
- 1991-11-29 KR KR1019910021718A patent/KR100190332B1/ko not_active Expired - Fee Related
1994
- 1994-03-10 US US08/208,497 patent/US6281208B1/en not_active Expired - Fee Related
1996
- 1996-03-05 GR GR960400598T patent/GR3019195T3/el unknown

Also Published As

Publication number	Publication date
KR100190332B1 (ko)	1999-06-01
US6281208B1 (en)	2001-08-28
CA2056670C (en)	1998-05-26
EP0492164B1 (de)	1996-02-07
DE69117030D1 (de)	1996-03-21
EP0492164A1 (de)	1992-07-01
TW207952B (de)	1993-06-21
DK0492164T3 (da)	1996-06-24
GR3019195T3 (en)	1996-06-30
JP2975962B2 (ja)	1999-11-10
DE69117030T2 (de)	1996-07-18
KR920009402A (ko)	1992-06-25
CA2056670A1 (en)	1992-05-30
JPH06219950A (ja)	1994-08-09

Similar Documents

Publication	Publication Date	Title
FR2673538B1 (fr)	1995-05-12	Composition a base de 3-[2-(dimethylamino)ethyl]-n-methyl-1h-indole-5 methanesulfonamide pour l'administration buccale.
FI950947A0 (fi)	1995-03-01	Oraalisesti annettavat farmaseuttiset formulaatiot
ES2235158T5 (es)	2016-05-25	Utilización de fluprostenol isopropil éster para la fabricación de un medicamento para el tratamiento del glaucoma y de la hipertensión ocular
NO166448C (no)	1991-07-24	Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidindioner.
FI930747A0 (fi)	1993-02-19	Heterocykliska foereningar och deras framstaellning och anvaendning
ATE121295T1 (de)	1995-05-15	Augentropfenarzneimittel.
NZ237309A (en)	1993-02-25	1-(2-(4-morpholino)ethyl)-3-(arylcarbonyl)-indole derivatives and pharmaceutical compositions
WO1999012570A3 (en)	1999-08-19	Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
CA2041417A1 (en)	1991-11-02	Treatment of pancreatic disease with 15-keto-prostaglandin compounds
LV10268A (lv)	1994-10-20	Terapeitiski aktivs benzimidazols un ta iegusanas panemiens
CA2046069A1 (en)	1992-01-11	Treatment of inflammatory diseases with 15-keto-prostaglandin compounds
CA2067224A1 (en)	1991-06-02	Hirudin/polyalkylene glycol conjugates
DE69117030D1 (de)	1996-03-21	Therapeutisches Mittel gegen Glaukom, das 2-Phenyl-3-oxo-2H-1,4-Benzothiazinderivate enthält
NO980058L (no)	1998-03-06	Opthalmiske preparater
ATE241980T1 (de)	2003-06-15	Neue inhalationspräparate enthaltend cr 2039 (andolast)
EP0503079A4 (en)	1992-10-28	Pyridazinone-substituted ethynylphenyl derivative and remedy for circulatory organ disease containing the same as active ingredient
GB9420747D0 (en)	1994-11-30	1,5 benzodiazepine derivatives
RU92006715A (ru)	1996-04-20	Местноанестезирующее средство для глаз
DE69635775D1 (de)	2006-04-13	Medikament gegen pulmonale herzprobleme
ES2170168T3 (es)	2002-08-01	Composiciones recubiertas entericamente de derivados de 1,5-benzodiacepina con actividad antagonista o agonista de cck.
SE9602262D0 (sv)	1996-06-06	New use of derivatives of cystine
ATE109003T1 (de)	1994-08-15	Therapeutisches mittel gegen pollakiurie, harndrang oder harninkontinenz, das alpha-phenyl- alpha-pyridylalkan-carbonsäurederivate enthält.
ITMI930843U1 (it)	1995-04-29	Macchina automatica di irruvidimento controllato di un bordo di tomaia
DK140389A (da)	1989-09-25	Antihypertensivt praeparat
GR3018126T3 (en)	1996-02-29	4-[(Thiophene-2-carbonyl)oxy]pyrrolidine-2-carboxylic acid, its preparation and its use as anti-inflammatory and anti-dystrophic agent.

Legal Events

Date	Code	Title	Description
1996-07-15	UEP	Publication of translation of european patent specification
2005-08-15	REN	Ceased due to non-payment of the annual fee